KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Emergent BioSolutions (EBS) over the last 11 years, with Q3 2025 value amounting to $3.7 million.

  • Emergent BioSolutions' Short-term Investments fell 4307.69% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 4307.69%. This contributed to the annual value of $6.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Emergent BioSolutions reported Short-term Investments of $3.7 million as of Q3 2025, which was down 4307.69% from $3.7 million recorded in Q2 2025.
  • Emergent BioSolutions' Short-term Investments' 5-year high stood at $6.5 million during Q3 2024, with a 5-year trough of $100000.0 in Q3 2022.
  • Over the past 4 years, Emergent BioSolutions' median Short-term Investments value was $350000.0 (recorded in 2021), while the average stood at $1.9 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Short-term Investments plummeted by 5000.0% in 2022, and later soared by 64000.0% in 2025.
  • Quarter analysis of 4 years shows Emergent BioSolutions' Short-term Investments stood at $200000.0 in 2021, then tumbled by 50.0% to $100000.0 in 2022, then surged by 6000.0% to $6.1 million in 2024, then crashed by 39.34% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q3 2025, $3.7 million for Q2 2025, and $3.7 million during Q1 2025.